N2VATE Develops Retail Chain Distribution for Medical and Healthcare Products

September 7. 2012  Westminster, California USA

For the last three months N2VATE has been working to develop inroads into US and International retail chain / retail drug chain outlets.  Responding to the need of clients to place their healthcare and medical device products into retail distribution, a new and focused effort was executed to develop connectivity to the more than 100,000+ retail chain outlets in the USA as well as select international stores.  ” The initial drive was to connect to the drug retail chains, but it is not limited to only those venues,” said Don Kloos, president and CEO of N2VATE.  “We saw it as an opportunty to expand our sales and marketing services, in addition to the B2B focus for medical device and scientific instruments, ”  Kloos said.  In order to accomplish this, N2VATE brought in experienced retail expertise in Mr. Doug Eder.  Eder is in charge of retail sales & marketing efforts and brings decades of successful retail management and marketing experience. “We’re making signficant inroads into major chains such as Walgreens, CVS, and RiteAid, to name a few, for our clients product lines”, said Eder.  “We expect to continue gaining momentum and generate revenue in Q4 2012, while further expanding our representation of new product lines and new products.”

For further information about N2VATE and retail distribution, contact N2VATE at 714.897.9779, or info@N2VATE.com. There is also a Contact Form on its website at: http://www.n2vate.com/contact.html

Jobs Act and Crowdfunding for Startups and Early Stage Ventures

 

Jobs Act and Crowdfunding

The JOBS Act, which was signed into law on April 5, 2012, seems to offer a great way to capitalize startups, early stage, or even more mature ventures through crowdfundingAttorney for N2VATE, Eric Alspaugh, spent four hours researching the Act to gain some insights.  Here’s a brief review of his findings, below:

  •  According to the LAW, the SEC must issue regulations by  January 1, 2013 (270 days from passing the law).  None of the crowd source portals can begin operations before that.
  • The main issue will be the registration with SEC. The law makes it sound like the site must still have a broker dealer from a national association- which would make this difficult for most potential beneficiaries.
  • A big issue which everyone is missing, except for the lawyers, is that the Officers of the company will be personally liable – no corporate shield!
  • Another important issue is whether VC or other investors will be deterred from follow-on investment.
  • It appears that there is a million dollar limit.

Please post your own insights and knowledge.

Download a copy of the Jobs Act here: JOBS Act 2012

Download a copy of the Jobs Act Summary here: JOBS ACT Summary (2)1

For more information contact legal@N2VATE.com.

Below is a list of crowd funding resources from http://coolintl.com/  April, 2012:

Debt Funding via Crowdfunding

Variety & Creative Projects

Books: www.authr.com

 

Music

Film

Share Expenses

Charitable

Marketing, Communications, Media, Public Messages

App Software Development

Businesses / Ventures / Start ups

White Label Crowdfunding, Developer API, Crowdfunding Development Partners

N2VATE Announces Launch

November 10, 2011, Westminster California, USA.

Announcing the launch of N2VATE, located in Orange County, southern California, to service the medical device and scientific instrument space.  “We provide a business development platform for the inventor, start-up, entrepreneur, and early stage companies, in addition to established organizations, but we especially cater to the smaller ‘boutique’ products”, said Don Kloos, N2VATE founder and president.  Boutique medical devices would be simpler class I or II niche products and devices with IP that require smaller capitalization and have shorter time to market and revenue stream.

Drawing on its experience and that of its strategic partners, N2VATE provides complete business management for the development of medical devices and scientific instruments, two closely related fields,  from concept to development to manufacturing to market, and exit.

“We’re able to address all the aspects of the product lifecycle by providing highly professional expertise in the various disciplines necessary for success directly, or through our partners”, Kloos said.  This starts with business planning, funding, and exit strategies; then market analysis and validation; product design and engineering; prototyping and testing; regulatory compliance and quality management; tooling, packaging and contract manufacturing; marketing, sales, and distribution; and valuation, acquisition, and licensing options.

In keeping with current trends, N2VATE is experienced in international business venues and can even help start-ups who have decided to circumvent the current US regulatory bottleneck and access overseas markets first.  N2VATE also can find suitable OEM partners for out-licensing of medtech, bypassing most of the start-up process in exchange for earlier revenue stream.

N2VATE is differentiated from marketing firms or incubators, as its business model is based on active ‘product management’.  “We can contract as an outsourced business development manager, or jump right in and participate as a partner with equity or licensing value, which makes this ‘our baby’, too”, Kloos said.

N2VATE can be reached by phone at +1.714.897.9779, or by email at info@N2VATE.com, and there are several contact options, including product evaluation forms and NDA, from its website at http://www.n2vate.com/contact.html.